Evidence map›Paper›PMID 24945495›Full record

ArticlePLoS pathogens2014

Selective chemical inhibition of agr quorum sensing in Staphylococcus aureus promotes host defense with minimal impact on resistance.

Erin K Sully, Natalia Malachowa, Bradley O Elmore, Susan M Alexander, Jon K Femling, Brian M Gray, Frank R DeLeo, Michael Otto, Ambrose L Cheung, Bruce S Edwards and 4 more

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 220 papers.

0numbers the graph read from it
0cells of the map it votes in
220citing papers in PubMed
17.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

220 citing papers in PubMed, 366 citations in OpenAlex.

  1. Article
  2. Article
  3. Prevention and Treatment ofPathogens (Basel, Switzerland) · 2026
    Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. EngineeredBiochemistry · 2026
    Article
  10. Cucurbitacin B mitigatesJournal of pharmaceutical analysis · 2026
    Article
  11. Review
  12. Article
  13. A Small Molecule That Inhibits the Quorum Sensing Receptor AgrC inJournal of the American Chemical Society · 2026
    Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Review
  19. Biofilm-associated genes inFrontiers in microbiology · 2026
    Review
  20. Review

160 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 1 country.

Erin K SullyResearch Service, New Mexico Veterans Affairs Medical Center, Albuquerque, New Mexico, United States of America; Division of Infectious Diseases, Department of Internal Medicine, University of New Mexico School of Medicine, Albuquerque, New Mexico, United States of America.
Natalia MalachowaLaboratory of Human Bacterial Pathogenesis, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, Montana, United States of America.
Bradley O ElmoreCollege of Pharmacy, University of New Mexico, Albuquerque, New Mexico, United States of America.
Susan M AlexanderResearch Service, New Mexico Veterans Affairs Medical Center, Albuquerque, New Mexico, United States of America.
Jon K FemlingDepartment of Emergency Medicine, University of New Mexico, Albuquerque, New Mexico, United States of America.
Brian M GrayResearch Service, New Mexico Veterans Affairs Medical Center, Albuquerque, New Mexico, United States of America; College of Pharmacy, University of New Mexico, Albuquerque, New Mexico, United States of America.
Frank R DeLeoLaboratory of Human Bacterial Pathogenesis, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, Montana, United States of America.
Michael OttoLaboratory of Human Bacterial Pathogenesis, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.
Ambrose L CheungDepartment of Microbiology, Dartmouth Medical School, Hanover, New Hampshire, United States of America.
Bruce S EdwardsCenter for Molecular Discovery and Department of Pathology, University of New Mexico School of Medicine, Albuquerque, New Mexico, United States of America.
Larry A SklarCenter for Molecular Discovery and Department of Pathology, University of New Mexico School of Medicine, Albuquerque, New Mexico, United States of America.
Alexander R HorswillDepartment of Microbiology, Carver College of Medicine, University of Iowa, Iowa City, Iowa, United States of America.
Pamela R HallCollege of Pharmacy, University of New Mexico, Albuquerque, New Mexico, United States of America.
Hattie D GreshamResearch Service, New Mexico Veterans Affairs Medical Center, Albuquerque, New Mexico, United States of America; Division of Infectious Diseases, Department of Internal Medicine, University of New Mexico School of Medicine, Albuquerque, New Mexico, United States of America.
University of New Mexico · USNational Institute of Allergy and Infectious Diseases · USDartmouth College · USUniversity of Iowa · US

Funding

Staphylococcal pathogenesisZIAAI000904 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI OTTO, MICHAEL · 2009 to 2025
$22.6M
FAIR Data Competency and Machine Learning Readiness for Biomedical ScientistsK12GM088021 · NIGMS · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI REBECCA S. HARTLEY, Diane Lidke · 2009 to 2026
$16.4M
Yeast Biology ConsortiumU54MH084690 · NIMH · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI TEGOS, GEORGE P · 2008 to 2013
$14.4M
Mechanisms of Staphylococcus aureus virulenceZIAAI001079 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI DELEO, FRANK · 2009 to 2025
$11.8M
New Mexico Molecular Libraries Screening Center(RMI)U54MH074425 · NIMH · UNIVERSITY OF NEW MEXICO · PI SKLAR, LARRY A. · 2005 to 2008
$10.0M
Biology of Infectious Diseases &InflammationT32AI007538 · NIAID · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI Michelle A Ozbun · 1998 to 2026
$5.2M
Apolipoprotein B and Control of S. aureus Quorum SensingR01AI091917 · NIAID · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI HALL, PAMELA RANEL · 2011 to 2015
$1.9M
Mechanistic Studies on Staphylococcal Quorum Quenching Natural ProductsR01AT007052 · NCCIH · EMORY UNIVERSITY · PI QUAVE, CASSANDRA LEAH · 2012 to 2016
$1.8M
Intramural NIH HHSNCCIH NIH HHS AT007052NCCIH NIH HHS R01 AT007052NIAID NIH HHS R01 AI091917NIAID NIH HHS T32 AI007538NIGMS NIH HHS 5K12 GM088021NIGMS NIH HHS K12 GM088021NIMH NIH HHS U54 MH074425NIMH NIH HHS U54MH074425NIMH NIH HHS U54 MH084690NIMH NIH HHS U54MH084690NIMH NIH HHS X01MH078952
6 · The paper itself

Abstract

Bacterial signaling systems are prime drug targets for combating the global health threat of antibiotic resistant bacterial infections including those caused by Staphylococcus aureus. S. aureus is the primary cause of acute bacterial skin and soft tissue infections (SSTIs) and the quorum sensing operon agr is causally associated with these. Whether efficacious chemical inhibitors of agr signaling can be developed that promote host defense against SSTIs while sparing the normal microbiota of the skin is unknown. In a high throughput screen, we identified a small molecule inhibitor (SMI), savirin (S. aureus virulence inhibitor) that disrupted agr-mediated quorum sensing in this pathogen but not in the important skin commensal Staphylococcus epidermidis. Mechanistic studies employing electrophoretic mobility shift assays and a novel AgrA activation reporter strain revealed the transcriptional regulator AgrA as the target of inhibition within the pathogen, preventing virulence gene upregulation. Consistent with its minimal impact on exponential phase growth, including skin microbiota members, savirin did not provoke stress responses or membrane dysfunction induced by conventional antibiotics as determined by transcriptional profiling and membrane potential and integrity studies. Importantly, savirin was efficacious in two murine skin infection models, abating tissue injury and selectively promoting clearance of agr+ but not Δagr bacteria when administered at the time of infection or delayed until maximal abscess development. The mechanism of enhanced host defense involved in part enhanced intracellular killing of agr+ but not Δagr in macrophages and by low pH. Notably, resistance or tolerance to savirin inhibition of agr was not observed after multiple passages either in vivo or in vitro where under the same conditions resistance to growth inhibition was induced after passage with conventional antibiotics. Therefore, chemical inhibitors can selectively target AgrA in S. aureus to promote host defense while sparing agr signaling in S. epidermidis and limiting resistance development.

Indexed as

AnimalsAnti-Bacterial AgentsBacterial ProteinsCell Line, TransformedDrug DiscoveryGenes, ReporterHigh-Throughput Screening AssaysImmunity, InnateMacrophagesMaleMice, HairlessMice, KnockoutMolecular ConformationMolecular Docking SimulationMolecular Targeted TherapyMutationAgr protein, Staphylococcus aureusAnti-Bacterial AgentsBacterial ProteinsQuinazolinonessavirinTrans-ActivatorsTriazoles

Identifiers

PMID24945495
PMCPMC4055767
OpenAlexW2089700892

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.